These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Physiologic variables and functional status independently predict COPD hospitalizations and emergency department visits in patients with severe COPD. Fan VS; Ramsey SD; Make BJ; Martinez FJ COPD; 2007 Mar; 4(1):29-39. PubMed ID: 17364675 [TBL] [Abstract][Full Text] [Related]
23. Prediction of risk of COPD exacerbations by the BODE index. Marin JM; Carrizo SJ; Casanova C; Martinez-Camblor P; Soriano JB; Agusti AG; Celli BR Respir Med; 2009 Mar; 103(3):373-8. PubMed ID: 19013781 [TBL] [Abstract][Full Text] [Related]
26. The clinical and integrated management of COPD. Bettoncelli G; Blasi F; Brusasco V; Centanni S; Corrado A; De Benedetto F; De Michele F; Di Maria GU; Donner CF; Falcone F; Mereu C; Nardini S; Pasqua F; Polverino M; Rossi A; Sanguinetti CM Sarcoidosis Vasc Diffuse Lung Dis; 2014 May; 31 Suppl 1():3-21. PubMed ID: 24820963 [TBL] [Abstract][Full Text] [Related]
27. Long term effects of an integrated care intervention on hospital utilization in patients with severe COPD: a single centre controlled study. Titova E; Steinshamn S; Indredavik B; Henriksen AH Respir Res; 2015 Feb; 16(1):8. PubMed ID: 25645122 [TBL] [Abstract][Full Text] [Related]
28. Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation. Garcia-Rio F; Lores V; Mediano O; Rojo B; Hernanz A; López-Collazo E; Alvarez-Sala R Am J Respir Crit Care Med; 2009 Sep; 180(6):506-12. PubMed ID: 19542481 [TBL] [Abstract][Full Text] [Related]
29. Six-minute-walk distance and accelerometry predict outcomes in chronic obstructive pulmonary disease independent of Global Initiative for Chronic Obstructive Lung Disease 2011 Group. Durheim MT; Smith PJ; Babyak MA; Mabe SK; Martinu T; Welty-Wolf KE; Emery CF; Palmer SM; Blumenthal JA Ann Am Thorac Soc; 2015 Mar; 12(3):349-56. PubMed ID: 25568929 [TBL] [Abstract][Full Text] [Related]
30. The effect of positive expiratory pressure (PEP) therapy on symptoms, quality of life and incidence of re-exacerbation in patients with acute exacerbations of chronic obstructive pulmonary disease: a multicentre, randomised controlled trial. Osadnik CR; McDonald CF; Miller BR; Hill CJ; Tarrant B; Steward R; Chao C; Stodden N; Oliveira CC; Gagliardi N; Holland AE Thorax; 2014 Feb; 69(2):137-43. PubMed ID: 24005444 [TBL] [Abstract][Full Text] [Related]
31. The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort. Casanova C; de Torres JP; Aguirre-Jaíme A; Pinto-Plata V; Marin JM; Cordoba E; Baz R; Cote C; Celli BR Am J Respir Crit Care Med; 2011 Nov; 184(9):1015-21. PubMed ID: 21836135 [TBL] [Abstract][Full Text] [Related]
32. An integrated index combined by dynamic hyperinflation and exercise capacity in the prediction of morbidity and mortality in COPD. Ozgür ES; Nayci SA; Özge C; Taşdelen B Respir Care; 2012 Sep; 57(9):1452-9. PubMed ID: 22348294 [TBL] [Abstract][Full Text] [Related]
33. Assessing need for long-term oxygen therapy: a comparison of conventional evaluation and measures of ambulatory oximetry monitoring. Fussell KM; Ayo DS; Branca P; Rogers JT; Rodriguez M; Light RW Respir Care; 2003 Feb; 48(2):115-9. PubMed ID: 12556251 [TBL] [Abstract][Full Text] [Related]
34. Fetuin-A is associated with disease severity and exacerbation frequency in patients with COPD. Minas M; Mystridou P; Georgoulias P; Pournaras S; Kostikas K; Gourgoulianis KI COPD; 2013 Feb; 10(1):28-34. PubMed ID: 23272665 [TBL] [Abstract][Full Text] [Related]
35. Comparison of 2011 and 2007 Global Initiative for Chronic Obstructive Lung Disease guidelines for predicting mortality and hospitalization. Johannessen A; Nilsen RM; Storebø M; Gulsvik A; Eagan T; Bakke P Am J Respir Crit Care Med; 2013 Jul; 188(1):51-9. PubMed ID: 23590268 [TBL] [Abstract][Full Text] [Related]
36. Predictors of emergency department visit disposition for patients with chronic obstructive pulmonary disease. Parshall MB; Doherty GS Heart Lung; 2006; 35(5):342-50. PubMed ID: 16963366 [TBL] [Abstract][Full Text] [Related]
37. Efficacy of aclidinium bromide 400 μg twice daily compared with placebo and tiotropium in patients with moderate to severe COPD. Fuhr R; Magnussen H; Sarem K; Llovera AR; Kirsten AM; Falqués M; Caracta CF; Garcia Gil E Chest; 2012 Mar; 141(3):745-752. PubMed ID: 21903737 [TBL] [Abstract][Full Text] [Related]
38. Long-term outcomes in mild/moderate chronic obstructive pulmonary disease in the European community respiratory health survey. de Marco R; Accordini S; Antò JM; Gislason T; Heinrich J; Janson C; Jarvis D; Künzli N; Leynaert B; Marcon A; Sunyer J; Svanes C; Wjst M; Burney P Am J Respir Crit Care Med; 2009 Nov; 180(10):956-63. PubMed ID: 19696441 [TBL] [Abstract][Full Text] [Related]
39. The CAT (COPD Assessment Test) questionnaire as a predictor of the evolution of severe COPD exacerbations. García-Sidro P; Naval E; Martinez Rivera C; Bonnin-Vilaplana M; Garcia-Rivero JL; Herrejón A; Malo de Molina R; Marcos PJ; Mayoralas-Alises S; Ros JA; Valle M; Esquinas C; Barrecheguren M; Miravitlles M Respir Med; 2015 Dec; 109(12):1546-52. PubMed ID: 26542727 [TBL] [Abstract][Full Text] [Related]